Jeena Sikho Lifecare Q4 FY26: Growth Holds, Margins Moderate Sequentially

Q4 FY26 revenue from operations was 215.55 crore, EBITDA was 77.98 crore (36% margin), and PAT was 45.35 crore (21% margin).

FY26 revenue from operations was 801.35 crore versus 469.07 crore in FY25, with EBITDA of 349.63 crore (44% margin) versus 140.60 crore (30% margin) in FY25 and PAT of 222.18 crore versus 79.94 crore.

The presentation reports FY26 services revenue of 385 crore (48% contribution) and products revenue of 416 crore (52% contribution).

The company reports 61 operational hospitals, 58 operational clinics and day care centres, 2,861 total beds, and 2,300 operational beds across 23 states and 100+ cities and towns.

FY26 IPD patient volumes were 40,454 and OPD patient volumes were about 5.70 lakh, with consultations (OPD and VOPD) reported at 2,27,127 for FY26.

Management attributed sequential margin moderation mainly to higher provisioning related to labour code amendments, ESOP provisioning, and performance-linked bonuses paid at the close of the financial year.

The company listed improving utilization of existing assets, adding new centres and beds, tapping OTC channels, expanding products, enabling cashless insurance, increasing government and AYUSH panel coverage, and overseas expansion beginning with UAE.